PillLabeler · US market
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. is a US drug labeler with US FDA registrations covering 25 drug concepts (24 currently active) across 115 packages. It is currently the only active US supplier of 17 drugs.
ACTIVE — US
openFDA · updated weekly
Labeler codes0597
Active drugs24
Registrations63 active / 66
Packages115
Sole supplier of17 drugs
Portfolio25 drugs · US
Every drug concept this labeler has US registrations for, by package count.
| Drug | Type | NDCs | Packages | Status |
|---|---|---|---|---|
| Adalimumab-Adbm kit | rx | 12 | 12 | SUPPLYING |
| Empagliflozin, Metformin Hydrochloride tablet, extended release | rx | 4 | 10 | SUPPLYING |
| Empagliflozin And Metformin Hydrochloride tablet | rx | 4 | 9 | SUPPLYING |